Form 8-K - Current report:
SEC Accession No. 0001437749-21-001499
Filing Date
2021-01-28
Accepted
2021-01-28 16:30:11
Documents
7
Period of Report
2021-01-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20210125_8k.htm 8-K 21394
2 EXHIBIT 99.1 ex_222312.htm EX-99.1 3370
3 a01.jpg GRAPHIC 146860
4 a02.jpg GRAPHIC 195181
5 a03.jpg GRAPHIC 197283
6 a04.jpg GRAPHIC 107546
7 b01.jpg GRAPHIC 172686
  Complete submission text file 0001437749-21-001499.txt   1154205
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 21565522
SIC: 2834 Pharmaceutical Preparations